Healthdirect Free Australian health advice you can count on.

Medical problem? Call 1800 022 222. If you need urgent medical help, call triple zero immediately

healthdirect Australia is a free service where you can talk to a nurse or doctor who can help you know what to do.

beginning of content

Brand name: Amoxyclav 875/125 (AN)

Amoxyclav 875/125 (AN) is a medicine containing the active ingredient(s) amoxicillin + clavulanic acid. On this page you will find out more about Amoxyclav 875/125 (AN), including side effects, age restrictions, food interactions and whether the medicine is subsidised by the government on the pharmaceutical benefits scheme (PBS)

You should seek medical advice in relation to medicines and use only as directed by a healthcare professional. Always read the label. If symptoms persist see your healthcare professional. healthdirect medicines information is not intended for use in an emergency. If you are suffering an acute illness, overdose, or emergency condition, call triple zero (000) and ask for an ambulance.

Reasonable care has been taken to provide accurate information at the time of creation. This information is not intended to substitute medical advice, diagnosis or treatment and should not be exclusively relied on to manage or diagnose a medical condition. Please refer to our terms and conditions.

Active ingredient in this medicine: amoxicillin + clavulanic acid

Information for medicine and pack size:
Amoxyclav 875/125 (AN) film-coated tablet, 10

Consumer Medicine Information leaflet:

This leaflet may also be found inside the medicine package. It contains information on side effects, age restrictions and other useful data.

Read leaflet

What this medicine is for

Amoxicillin and clavulanic acid tablets are indicated for short-term treatment of bacterial infections at the following sites when caused by sensitive organisms: - Urinary tract infections (uncomplicated and complicated). - Lower respiratory tract infections, including community acquired pneumonia and acute exacerbations of chronic bronchitis. - Upper respiratory tract infections, such as sinusitis, otitis media and recurrent tonsillitis. - Skin and skin structure infections. Appropriate culture and susceptibility studies should be performed to identify the causative organism(s) and determine its (their) susceptibility to Amoxyclave Duo SCP and Amoxyclave Duo Forte SCP tablets. However, when there is reason to believe an infection may involve any of the beta-lactamase producing organisms listed in Microbiology, therapy may be instituted prior to obtaining the results from bacteriological and susceptibility studies. Once these results are known, therapy should be adjusted if appropriate. The treatment of mixed infections caused by amoxicillin susceptible organisms and beta-lactamase producing organisms susceptible to Amoxyclave Duo SCP and Amoxyclave Duo Forte Scp tablets should not require the addition of another antibiotic due to the amoxicillin content of these products.

Table of characteristics
Table of characteristics
Active ingredient
Visual appearance White, convex capsule shaped film coated tablet

Images are the copyright of the Pharmacy Guild of Australia

Dosage Form Tablet, film coated
Route of administration Oral
Medicine schedule
10 tablets: Prescription Only Medicine, or Prescription Animal Remedy

There is one type of pack available.

Pack type 1
Pack type 1
Type Blister Pack
Storage temperature Store below 25 degrees Celsius
Storage conditions Protect from Moisture
Life time 2 Years
We were unable to verify that this medicine is available on the PBS (Pharmaceutical Benefits Scheme). Please consult your pharmacist if you need further information

The PBS provides a list of government subsidised medicines available to be dispensed to patients. Further information can be found on the Pharmaceutical Benefits Scheme website.

Go to PBS site

Is this medication banned in sport?

Check if you can use your medicine whilst playing sport. Search the Australian Sports Anti-Doping Authority (ASADA) database that provides information about the prohibited status of specific medications and/or the active ingredient based on the current World Anti-Doping Agency (WADA) Prohibited List.

Go to ASADA site

The information displayed on this page is authored by Healthdirect Australia, or obtained from trusted sources.

Need more information?

These trusted information partners have more on this topic.

Found 4 results

AmoxyClav RBX 875/125 Tablets - myDr.com.au

AmoxyClav RBX 875/125 Tablets - Consumer Medicines Information leaflets of prescription and over-the-counter medicines

Read more on myDr – Consumer Medicine Information website

AmoxyClav GH 875/125 Tablets - myDr.com.au

AmoxyClav GH 875/125 Tablets - Consumer Medicines Information leaflets of prescription and over-the-counter medicines

Read more on myDr – Consumer Medicine Information website

Pharmacor AmoxyClav 500/125 Tablets - myDr.com.au

Pharmacor AmoxyClav 500/125 Tablets - Consumer Medicines Information leaflets of prescription and over-the-counter medicines

Read more on myDr – Consumer Medicine Information website

Amoxyclav AN 500/125 Tablets - myDr.com.au

Amoxyclav AN 500/125 Tablets - Consumer Medicines Information leaflets of prescription and over-the-counter medicines

Read more on myDr – Consumer Medicine Information website

Healthdirect 24hr 7 days a week hotline

24 hour health advice and information you can count on

1800 022 222

Government Accredited with over 140 information partners

We are a government-funded service, providing quality, approved health information

Australian Government, health department logo ACT Government logo New South Wales government, health department logo Northen Territory Government logo Government of South Australia, health department logo Tasmanian government logo Government of Western Australia, health department logo
Feedback